Discussions that mention hyzaar

High & Low Blood Pressure board

Hello all, I was wondering if someone can help me? I am going for a second round of interviewing for a pharm rep job next week and I was wondering if you can tell me the differance between Diovan and Micardis?

I know that Atacand, Avalide, Avapro, Cozaar, Hyzaar and Teveten are all competors. I am applying to be a rep for Micardis and my interviewer specifically mentioned Diovan as their competitor. I am wondering why Diovan has 60% of the market share and Micardis has only 4%? Can someone help me please? Thanks alot, I am new to this site but am hopeful in my new career I can be more aversed to healthcare advances.

There's not a lot of difference among the ARB's...all are weak antihypertensives that block the attatchment of angiotensin-2.
Probably Diovan, with the intese backing of its powerful maufacturer, Novartis, has more money to spend on doctor "advertising" than does the lesser light, Boehringer-Ingleheim, the maker of Micardis.

The 60% figure for Diovan makes me scratch my head a bit; after all there are some strong competitors like Cozaar/ Hyzaar, Avapro, Atacand, Benicar and even the lowly Teveten along with the Micardis.
It seems almost impossible to me that in that horserace, Diovan could get 60% of the market?????? Are you sure?